ARCHIVES

Non-Adherence To Protocol Explains Outcome Differences In Hispanic Children With ALL

This article is from The Cancer Letter archive.

Vol. 33 No. 12 | December 31, 2010

Download PDF Visit The Full Archive

Related Articles

Palmetto Establishes Coverage For Thyroid Genomic Test

January 27, 2012

Includes 8-page Business & Regulatory Report.

April 11, 2003

In Brief: Holland Retires As Center Director, Replaced By NCI’s Aaronson; Lab Chiefs Leaving NCI

September 24, 1993

White House names five to NCAB, reappoints Niederhuber as chairman.

June 25, 2004

FDA examining endpoints for approval of cancer therapies, potential departure from survival as the gold standard, Oncology Division Director Richard Pazdur says in interview.

November 7, 2003

RFA For Patient Compliance Study

September 26, 1980